Anixa Biosciences Inc.
ANIX
NSC
Sector: Healthcare
Industry: Diagnostics & Research
4.69
USD
-0.61
(-11.51%)
Optionable: Yes Market Cap: 163 M 90-day average vol: 88,414
Previous close: 5.3 Open: 5.25 Bid: 4.97 Ask: 4.97
52 week range
2.30 6.25
Last updated: Thursday 29th September 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Financials
ANIX Income Statement
Annual
| Oct-12 | Oct-13 | Oct-14 | Oct-15 | Oct-16 | Oct-17 | Oct-18 | Oct-19 | Oct-20 | Oct-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 940010 | 388850 | 4 M | 9 M | 300000 | 362500 | 1 M | 250000 | 0 | 512500 |
| Cost of sales | -7234 | 316658 | 2 M | 3 M | -174546 | -307172 | 406244 | -347616 | -90157 | 325138 |
| Gross operating profit | 940010 | 72192 | 2 M | 6 M | 115917 | 301160 | 362525 | 131308 | 0 | 127498 |
| Selling Gen & administrative expense | 3 M | 8 M | 6 M | 6 M | 3 M | 4 M | 7 M | 6 M | 6 M | 7 M |
| Research & development expense | 2 M | 0 | 0 | 711391 | 2 M | 2 M | 7 M | 5 M | 4 M | 6 M |
| Operating income | -4 M | -8 M | -5 M | -944759 | -5 M | -6 M | -14 M | -11 M | -10 M | -13 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | -114037 | -1 M | -3 M | 0 | 0 | 2 M | -582979 | -418750 | -148084 | 5447 |
| Pre-tax Income (EBT) | -4 M | -10 M | -10 M | -1 M | -5 M | -5 M | -14 M | -12 M | -10 M | -13 M |
| Income taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from total operations | -4 M | -10 M | -10 M | -1 M | -5 M | -5 M | -14 M | -12 M | -10 M | -13 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | -4 M | -10 M | -10 M | -1 M | -5 M | -5 M | -14 M | -12 M | -10 M | -13 M |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | 2 M | N/A | N/A | N/A | N/A |
| Net income available for common | -4 M | -10 M | -10 M | -1 M | -5 M | -7 M | -14 M | -12 M | -10 M | -13 M |
| Depreciation | 7234 | 0 | 314453 | 337806 | 358629 | 368512 | 343731 | 466308 | 90157 | 59864 |
| Amortization | 0 | 0 | 314453 | 325291 | 325296 | 325296 | 325296 | 418750 | 0 | 0 |
| Operating income before depreciation (EBITDA) | -4 M | -9 M | -8 M | -589331 | -4 M | -4 M | -13 M | -11 M | -10 M | -13 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | -0.46 | -1.14 | -0.91 | -0.15 | -0.57 | -0.58 | -0.79 | -0.59 | -0.45 | -0.45 |
| Diluted EPS total | -0.46 | -1.14 | -0.91 | -0.15 | -0.57 | -0.58 | -0.79 | -0.59 | -0.45 | -0.45 |
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONSGet started today